APG-5918

· Ascentage Pharma Group Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for APG-5918, covering 2026-04-15 to 2026-04-15. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of APG-5918. [Phase 1]